Docebo IncDCBO
Price$23.44

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $251M+14.3% YoYTTM through 31 Dec 2025
Net Income $37.5M+40.3% YoYTTM through 31 Dec 2025
Free Cash Flow $27.2MTTM through 31 Dec 2025

Margins

Current
Gross Margin78.1%
EBITDA Margin10.5%
Operating Margin35.4%
Net Margin-2.5%

Returns

50.6%ROE
18.2%ROA
47.4%ROIC

Balance Sheet Health

Debt / Equity-136.06x
Current Ratio1.22x
Net Debt$15.9M
Cash & Equivalents$74M

Quality Metrics

Piotroski F-Score5 / 9
FCF Margin10.8%
Rule of 4020.1
Earnings-Beat Rate75.0%

Dividend

No dividend

Capital Allocation

Capex Intensity1.5%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.